ClinicalTrials.govpublic full text
Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide
hodgkin's lymphoma, leukemia, myelodysplastic syndrome(mds), multiple myeloma, non hodgkin's lymphoma, nonmyeloablative, allogeneic, bone marrow transplant (bmt), tacrolimus, cyclophosphamide, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 833873
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.